Ignite Creation Date:
2024-05-05 @ 9:59 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01008150
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2009-11-03
Brief Title:
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib andor Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
NSABP Foundation Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-03
First Submit QC Date:
November 4 2009
Study First Post Date:
2009-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-04
Last Update Post Date:
2021-10-25
Last Update Post Date Type:
ACTUAL